Venture Life Group (LON:VLG) Announces Quarterly Earnings Results

Venture Life Group (LON:VLG) released its earnings results on Tuesday. The company reported GBX 4.10 EPS for the quarter, Digital Look Earnings reports. Venture Life Group had a net margin of 17.42% and a return on equity of 7.82%.

Venture Life Group Trading Down 4.7%

Shares of VLG stock traded down GBX 3.20 during trading hours on Tuesday, hitting GBX 65. 917,313 shares of the company were exchanged, compared to its average volume of 272,819. The firm has a fifty day moving average of GBX 67.48 and a 200 day moving average of GBX 65.11. The company has a quick ratio of 1.48, a current ratio of 4.71 and a debt-to-equity ratio of 0.82. Venture Life Group has a 1 year low of GBX 52 and a 1 year high of GBX 72. The firm has a market cap of £78.03 million, a PE ratio of 14.87, a PEG ratio of 5.67 and a beta of 0.23.

About Venture Life Group

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.